Helping smokers quit improves health and budgets.

Area of Science:

• Public Health
• Health Economics

Background:

• Smoking-related illnesses represent a substantial financial burden on healthcare systems, accounting for approximately 11% of Medicaid expenditures.
• Effective tobacco cessation interventions are crucial for reducing healthcare costs and improving population health outcomes.

Purpose of the Study:

• To evaluate the impact of comprehensive tobacco cessation coverage within Medicaid programs.
• To assess the effectiveness of FDA-approved cessation medications in improving quit attempt success rates.

Main Methods:

• Analysis of Medicaid expenditures related to smoking-related illnesses.
• Review of state-level tobacco cessation coverage policies as of 2014.
• Comparison of quit attempt success rates with and without cessation medication assistance.

Main Results:

• Approximately 11% of Medicaid expenditures are attributed to the treatment of smoking-related illnesses.
• In 2014, only seven states offered comprehensive tobacco cessation coverage, encompassing counseling and FDA-approved medications.
• Tobacco cessation medication use increased the success rate of quit attempts from a baseline of 4-7% to 25%.

Conclusions:

• Comprehensive tobacco cessation programs, particularly those including FDA-approved medications, are highly effective in improving smoking cessation success rates.
• Expanding tobacco cessation coverage within Medicaid programs could lead to significant cost savings and public health benefits.
• Further research is warranted to explore barriers to comprehensive coverage and strategies for wider implementation.